Cancer Research Annual Meeting 2010  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 53, 4627-4632, October 1, 1993]
© 1993 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, L.
Right arrow Articles by Rhodes, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, L.
Right arrow Articles by Rhodes, J. M.

Reversible Inhibition of Proliferation of Epithelial Cell Lines by Agaricus bisporus (Edible Mushroom) Lectin1

Lugang Yu, David G. Fernig, John A. Smith, Jeremy D. Milton and Jonathan M. Rhodes2

Departments of Medicine [L. Y., J. D. M., J. M. R.] and Biochemistry [D. G. F., J. A. S.], University of Liverpool, P. O. Box 147, Liverpool L69 3BX, United Kingdom

2 To whom requests for reprints should be addressed, at the Department of Medicine, University of Liverpool, P. O. Box 147, Liverpool, L69 3BX United Kingdom.

Galactosyl β-1,3-N-acetyl galactosamine (Gal β-1,3-GalNAc) (Thomsen Friedenreich antigen), the Class I core sequence in O-linked oligosaccharide chains, behaves as an oncofetal antigen showing increased expression in many epithelial malignancies. Previous work has shown that peanut agglutinin (PNA), a lectin that binds Gal β-1,3-GalNAc, stimulates proliferation in HT-29 (human colon cancer) cells and normal human colonic epithelium and this implies that cell surface glycoproteins which express Gal β-1,3-GalNAc may play an important role in the regulation of epithelial cell proliferation. We have now studied the effect on epithelial cells of another dietary Gal β-1,3-GalNAc-binding lectin, the edible mushroom Agaricus bisporus lectin (ABL). This differs from PNA in its ability to bind also to sialylated Gal β-1,3-GalNAc.

In contrast to PNA, ABL (25 µg/ml) inhibited incorporation of [3H]-thymidine into DNA of HT29 colon cancer cells by 87% (95% confidence limit, 85–89%), Caco-2 colon cancer cells by 16% (95% confidence limit, 12–20%), MCF-7 breast cancer cells by 50% (95% confidence limit, 47–52%), and Rama-27 rat mammary fibroblasts by 55% (95% confidence limit, 51–60%) when these cells were grown for 24 h in serum-free medium. When assessed by cell count, similar inhibition of proliferation of HT29 cells by ABL was found. In the presence of 2% fetal calf serum (which contains the ABL-binding glycoprotein fetuin), the inhibitory effect of ABL on cell proliferation was still demonstrable but at increased ABL concentration (60 µg/ml for 49% inhibition). Ten µg/ml ABL completely abolished the stimulatory effect on [3H]thymidine incorporation of epidermal growth factor (100 pg/ml) and PNA (25 µg/ml) and markedly inhibited the stimulatory effect of insulin (50 ng/ml).

ABL (0.2 mg/ml) caused no cytotoxicity to HT29, MCF-7, and Rama-27 cells as measured by trypan blue exclusion, and inhibition of proliferation in HT29 cells caused by 50 µg/ml ABL was reversible after removal of the lectin. Binding studies with 125I-labeled ABL suggested a single class of binding site with an apparent Kd value of (4.12 ± 0.29) x 10–7 M with (3.6 ± 0.3) x 107 binding sites/cell.

A. bisporus lectin is a reversible noncytotoxic inhibitor of epithelial cell proliferation which deserves study as a potential agent for cancer therapy.

1 This work was supported by a bursary to L. Y. from the Commission of the European Community.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 5/18/93. Accepted 7/27/93.




This article has been cited by other articles:


Home page
MycologiaHome page
T.B. Ng, P. H.K. Ngai, and L. Xia
An agglutinin with mitogenic and antiproliferative activities from the mushroom Flammulina velutipes.
Mycologia, March 1, 2006; 98(2): 167 - 171.
[Abstract] [Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
U. Lindequist, T. H. J. Niedermeyer, and W.-D. Julich
The Pharmacological Potential of Mushrooms
Evid. Based Complement. Altern. Med., September 1, 2005; 2(3): 285 - 299.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
N. Yang, X. Tong, Y. Xiang, Y. Zhang, Y. Liang, H. Sun, and D.-C. Wang
Molecular Character of the Recombinant Antitumor Lectin from the Edible Mushroom Agrocybe aegerita
J. Biochem., August 1, 2005; 138(2): 145 - 150.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. E. Carrizo, S. Capaldi, M. Perduca, F. J. Irazoqui, G. A. Nores, and H. L. Monaco
The Antineoplastic Lectin of the Common Edible Mushroom (Agaricus bisporus) Has Two Binding Sites, Each Specific for a Different Configuration at a Single Epimeric Hydroxyl
J. Biol. Chem., March 18, 2005; 280(11): 10614 - 10623.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L.-G. Yu, L. C. Packman, M. Weldon, J. Hamlett, and J. M. Rhodes
Protein Phosphatase 2A, a Negative Regulator of the ERK Signaling Pathway, Is Activated by Tyrosine Phosphorylation of Putative HLA Class II-associated Protein I (PHAPI)/pp32 in Response to the Antiproliferative Lectin, Jacalin
J. Biol. Chem., October 1, 2004; 279(40): 41377 - 41383.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L.-G. Yu, N. Andrews, M. Weldon, O. V. Gerasimenko, B. J. Campbell, R. Singh, I. Grierson, O. H. Petersen, and J. M. Rhodes
An N-terminal Truncated Form of Orp150 Is a Cytoplasmic Ligand for the Anti-proliferative Mushroom Agaricus bisporus Lectin and Is Required for Nuclear Localization Sequence-dependent Nuclear Protein Import
J. Biol. Chem., June 28, 2002; 277(27): 24538 - 24545.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
B. J. Campbell, G. E. Rowe, K. Leiper, and J. M. Rhodes
Increasing the intra-Golgi pH of cultured LS174T goblet-differentiated cells mimics the decreased mucin sulfation and increased Thomsen-Friedenreich antigen (Gal{beta}1-3GalNac{{alpha}}-) expression seen in colon cancer
Glycobiology, May 1, 2001; 11(5): 385 - 393.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Mo, H. C. Winter, and I. J. Goldstein
Purification and Characterization of a Neu5Acalpha 2-6Galbeta 1-4Glc/GlcNAc-specific Lectin from the Fruiting Body of the Polypore Mushroom Polyporus squamosus
J. Biol. Chem., March 31, 2000; 275(14): 10623 - 10629.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
J M RHODES
Beans means lectins
Gut, May 1, 1999; 44(5): 593 - 594.
[Full Text]


Home page
GutHome page
M Jordinson, I El-Hariry, D Calnan, J Calam, and M Pignatelli
Vicia faba agglutinin, the lectin present in broad beans, stimulates differentiation of undifferentiated colon cancer cells
Gut, May 1, 1999; 44(5): 709 - 714.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L.-G. Yu, D. G. Fernig, M. R. H. White, D. G. Spiller, P. Appleton, R. C. Evans, I. Grierson, J. A. Smith, H. Davies, O. V. Gerasimenko, et al.
Edible Mushroom (Agaricus bisporus) Lectin, Which Reversibly Inhibits Epithelial Cell Proliferation, Blocks Nuclear Localization Sequence-dependent Nuclear Protein Import
J. Biol. Chem., February 19, 1999; 274(8): 4890 - 4899.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1993 by the American Association for Cancer Research.